FDA Inspection 1168538 — Jacek A. Zdybski, M.D., Ph.D.
The FDA completed an inspection of Jacek A. Zdybski, M.D., Ph.D. on Mar 18, 2022 in Ostrowiec Swietokrzyski. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ostrowiec Swietokrzyski (Poland)
Additional Details
Clinical Investigator (CI)